Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for ...

On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...

Rep. Mike Collins heavily criticized statements made by the Right Rev. Mariann Budde on Tuesday at the inaugural prayer ...

Millions of us take vitamins, minerals, and other supplements daily to improve our health and well-being—but taking certain ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

As Trump withdraws the US from the World Health Organisation, experts say his controversial new health secretary could have ...

Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO® alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms ...

Many Canadians struggle with SAD, a real form of depression that can make navigating the winter months extremely difficult.

Girls and women are more likely to steal than boys, experts explain. This is their advice for concerned parents.